Search
CareDx Inc
CDNAAdd to Watchlist
29.154USD
-0.096-0.33%
Market hours （ET）Quotes delayed by 15 min
1.50BMarket Cap
LossP/E TTM
More Details of CareDx Inc Company
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
CareDx Inc Info
Ticker SymbolCDNA
Company nameCareDx Inc
IPO dateJul 17, 2014
CEOHanna (John W)
Number of employees644
Security typeOrdinary Share
Fiscal year-endJul 17
Address8000 Marina Blvd
CityBRISBANE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94005
Phone14152872300
Websitehttps://www.caredx.com/
Ticker SymbolCDNA
IPO dateJul 17, 2014
CEOHanna (John W)
Company Executives of CareDx Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
28.79K
-25.66%
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
8.17K
-867.03%
Mr. George W. Bickerstaff, III
Mr. George W. Bickerstaff, III
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
FAQs
Who are the top five shareholders of CareDx Inc?
The top five shareholders of CareDx Inc are: Dr. Peter Maag, Ph.D.
How many institutions hold shares of CareDx Inc (CDNA)?
As of 2026Q1, 469 institutions hold shares of CareDx Inc, with a combined market value of approximately 52.46M, accounting for 101.54% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -9782235.00.
What is the biggest source of revenue for CareDx Inc?
In 2026Q1, the Testing Service revenue business generated the highest revenue for CareDx Inc, amounting to 274.50M and accounting for 72.27% of total revenue.